Mitotic Self-Renewal: The core principle of stem cell biology is the ability to undergo symmetric or asymmetric division. In symmetric division, one stem cell produces two identical undifferentiated daughter cells, ensuring the stem cell pool is maintained ().
Lineage Specification: During asymmetric division, a stem cell produces one identical stem cell and one progenitor cell that begins the path toward specialization (). This allows an organism to generate specialized tissue while simultaneously preserving its source of regenerative cells.
Genetic Control: Differentiation is governed by the selective expression of the genome. While every cell in an organism contains the same DNA, stem cells have a 'blank' profile where most genes are accessible, whereas specialized cells have silenced the genes they do not need for their specific role.
| Feature | Embryonic Stem Cells | Adult Stem Cells |
|---|---|---|
| Source | Early-stage embryos | Specific tissues (e.g., marrow, skin) |
| Differentiation | Can become ANY cell type | Limited to specific cell types |
| Ethics | High controversy (destruction of embryo) | Low controversy (consenting adults) |
| Rejection Risk | Higher (from donor embryo) | Lower (often from patient themselves) |
Donor Cells: Provide a ready supply but carry a high risk of rejection unless a close match is found. They require the patient to take lifelong medication that weakens the immune system.
Patient Cells: Eliminate the risk of rejection entirely because the antigens are recognized as 'self'. However, they are harder to obtain and may not be available for all types of required tissues.
Terminology Precision: When defining stem cells, always include two key points: they are undifferentiated and they can divide by mitosis an unlimited number of times. Missing either point often results in lost marks in descriptive questions.
Answering Ethical Questions: If asked about the disadvantages of embryonic stem cells, specify that the objection is based on the 'destruction of potential human life'. Simply saying 'it is bad' or 'it is wrong' is insufficient for an academic explanation.
Explaining Rejection: Ensure you connect the concept of rejection to antigens. The logic chain is: different genes different antigens immune system recognition as 'foreign' attack/rejection.
Potency vs. Source: Do not assume all stem cells are the same. In your answers, always specify if you are discussing embryonic stem cells (which can become anything) or adult stem cells (which are limited).
The 'Adult' Misnomer: Many students believe adult stem cells are only found in adults. In reality, 'adult stem cells' refers to any stem cell found in a post-embryonic organism, including infants and children.
Cancer Risk: A significant biological risk of stem cell therapy is uncontrolled division. Because stem cells divide so rapidly, there is a possibility that transplanted cells may form a tumor (cancer) rather than healthy tissue.
Virus Transmission: Like any biological transplant, there is a risk that the source cells could be infected with a virus that is then passed on to the recipient patient, complicating the treatment.
Immunology: Stem cell therapy is deeply intertwined with the study of the immune system. The success of a transplant depends on the Major Histocompatibility Complex (MHC), which determines how well the body accepts foreign biological material.
Genetics: The field of gene therapy often uses stem cells as a vehicle. By correcting a genetic defect in a stem cell and then allowing it to differentiate, scientists can potentially cure hereditary diseases at the cellular level.
Cell Biology: The study of stem cells provides deep insights into the cell cycle and the regulation of mitosis, helping researchers understand how 'normal' cells know when to stop dividing.